Corporate

Video: HiSeq X® Debuts at the Science Museum, London

Our Lives in Data exhibition highlights the technology revolution that will impact our lives

HiSeq X® Debuts at the Science Museum, London
21 July 2016

More information about our lives is being captured than ever before. It’s estimated that more than 90% of all available human data has been recorded in the last few years and Illumina is playing a key role in helping use genomic data to transform the world around us.

The internationally renowned, Science Museum, London is staging the Our Lives in Data exhibition to uncover some of the diverse ways our data is being collected, analyzed, and used. From toys that can understand a child’s personality and smarter public transport planning to new genomic technology that is helping uncover the causes of rare diseases and cancer; big data's invisible revolution has begun.

Illumina’s HiSeq X instrument will be on display as an example of how sequencing technology is playing a crucial part in helping amass the data in the 100,000 Genomes Project that will allow scientists to do pioneering research.

Sequencing the genome of a person with cancer or someone with a rare disease will help scientists and doctors understand how disease works. The 100,000 Genomes Project has the potential to transform the future of health care, with new and better tests, drugs, and treatment. In time, it is hoped it may bring benefits to thousands of patients and their families and form the foundation for genomic medicine in the UK’s National Health Service and healthcare systems around the world.   

As the amount of data collected grows, so does the debate around data ownership. The Our Lives in Data exhibition will help visitors to discover new tools designed to protect our data.  

The exhibition is open at: Science Museum, Exhibition Rd, London SW7 2DD. Admission is free.

Website: Our Lives in Data

Recent Articles

When CGP uncovers potential hereditary cancer risk
When CGP uncovers potential hereditary cancer risk
Early access users rave about Illumina’s new MiSeq i100 Series
Early access users rave about Illumina’s new MiSeq i100 Series
Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments